Synergistic FGF21-Inducing Systems for Personalized Nutrition and Health
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates FGF21-inducing Bifidobacterium strains with cutting-edge technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for personalized nutrition planning, FGF21 level monitoring, and data security.
Background and Problem Solved
The original patent disclosed a composition for promoting the secretion of FGF21, but it had limitations in terms of personalization, data tracking, and security. The new inventive concept addresses these limitations by incorporating synergistic combinations of technologies to provide a more comprehensive and effective solution.
Detailed Description of the Inventive Concept
The inventive concept comprises a system for personalized nutrition planning, which includes a database of user profiles, a database of FGF21-inducing Bifidobacterium strains, and a machine learning module for recommending a personalized FGF21-inducing Bifidobacterium strain to a user based on their profile and health goals. Additionally, the system includes a method for monitoring FGF21 levels in a subject using a wearable IoT device and a cloud-based analytics platform. Furthermore, a blockchain-based system is used to secure and track FGF21-related data, ensuring data integrity and confidentiality. The composition for promoting FGF21 secretion is also enhanced with a graphene-based material for improving the bioavailability of the bacterium. Finally, an AI-powered genomics tool is used to predict FGF21 responsiveness in a subject by analyzing their genetic profile and identifying genetic markers associated with FGF21 responsiveness.
Novelty and Inventive Step
The new claims introduce novel synergistic combinations of FGF21-inducing Bifidobacterium strains with AI, IoT, blockchain, and new materials, which provide a more comprehensive and effective solution for personalized nutrition planning, FGF21 level monitoring, and data security. The inventive step lies in the integration of these distinct technologies to create a more powerful system that overcomes the limitations of the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms for personalized nutrition planning, the integration of additional IoT devices for more comprehensive health tracking, or the development of new materials for enhancing the bioavailability of the bacterium. Variations of the blockchain-based system could include the use of different consensus algorithms or the integration of additional security protocols.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the personalized nutrition and health industries, with potential applications in areas such as precision medicine, health and wellness, and food technology. The target market includes companies and organizations involved in personalized nutrition, health monitoring, and data security, as well as individuals seeking personalized health solutions.
Original Patent Information
| Patent Number | US 11,857,579 |
|---|---|
| Title | Composition for promoting the secretion of FGF21 |
| Assignee(s) | Morinaga Milk Industry Co., Ltd. |